Rigel Pharmaceuticals, Inc. (RIGL)
41.20
-0.85
(-2.02%)
USD |
NASDAQ |
Dec 12, 11:32
Rigel Pharmaceuticals Research and Development Expense (Quarterly): 7.353M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| Amicus Therapeutics, Inc. | 23.42M |
| Perspective Therapeutics, Inc. | 19.56M |
| Nektar Therapeutics | 27.25M |